WO2008062476A3 - Pharmaceutical composition comprising rosuvastatin or pharmaceutically accepatble salts thereof - Google Patents

Pharmaceutical composition comprising rosuvastatin or pharmaceutically accepatble salts thereof Download PDF

Info

Publication number
WO2008062476A3
WO2008062476A3 PCT/IN2007/000506 IN2007000506W WO2008062476A3 WO 2008062476 A3 WO2008062476 A3 WO 2008062476A3 IN 2007000506 W IN2007000506 W IN 2007000506W WO 2008062476 A3 WO2008062476 A3 WO 2008062476A3
Authority
WO
WIPO (PCT)
Prior art keywords
rosuvastatin
salts
pharmaceutical composition
pharmaceutically
accepatble
Prior art date
Application number
PCT/IN2007/000506
Other languages
French (fr)
Other versions
WO2008062476A2 (en
Inventor
Abhay Mahajan
Kamal Mehta
Vijay Nasare
Pankaj Shinde
Original Assignee
Glenmark Pharmaceutical Ltd
Abhay Mahajan
Kamal Mehta
Vijay Nasare
Pankaj Shinde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceutical Ltd, Abhay Mahajan, Kamal Mehta, Vijay Nasare, Pankaj Shinde filed Critical Glenmark Pharmaceutical Ltd
Publication of WO2008062476A2 publication Critical patent/WO2008062476A2/en
Publication of WO2008062476A3 publication Critical patent/WO2008062476A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates generally to a pharmaceutical compositions comprising an HMG Co-A reductase inhibitor e.g.: rosuvastatin or pharmaceutically acceptable salts thereof and inorganic salt of a monovalent cation.
PCT/IN2007/000506 2006-10-31 2007-10-25 Pharmaceutical composition comprising rosuvastatin or pharmaceutically accepatble salts thereof WO2008062476A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1816/MUM/2006 2006-10-31
IN1816MU2006 2006-10-31
US87943207P 2007-01-09 2007-01-09
US60/879,432 2007-01-09

Publications (2)

Publication Number Publication Date
WO2008062476A2 WO2008062476A2 (en) 2008-05-29
WO2008062476A3 true WO2008062476A3 (en) 2008-10-16

Family

ID=39430181

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2007/000506 WO2008062476A2 (en) 2006-10-31 2007-10-25 Pharmaceutical composition comprising rosuvastatin or pharmaceutically accepatble salts thereof

Country Status (1)

Country Link
WO (1) WO2008062476A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200800269A2 (en) * 2008-01-15 2009-08-21 Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş. Stable pharmaceutical formulation and preparation methods
EA024554B1 (en) * 2008-06-27 2016-09-30 Крка, Товарна Здравил, Д.Д., Ново Место Solid dosage form comprising rosuvastatin, and process for preparation thereof
EP2138165A1 (en) 2008-06-27 2009-12-30 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition comprising a statin
JP2011525901A (en) * 2008-06-27 2011-09-29 アブディ イブラヒム イラク サナイ ベ ティカレット アノニム シルケティ Rosuvastatin calcium-containing pharmaceutical composition
MX344885B (en) * 2008-11-10 2017-01-10 Psicofarma S A De C V Process for obtaining a composition of rosuvastatin calcium and product obtained.
TR200902077A2 (en) 2009-03-17 2010-01-21 Sanovel İlaç San.Veti̇c.A.Ş. Stable rosuvastatin compositions
TR200904341A2 (en) * 2009-06-03 2010-12-21 Bi̇lgi̇ç Mahmut Stable pharmaceutical compositions containing rosuvastatin calcium.
WO2011152803A1 (en) * 2010-06-03 2011-12-08 Mahmut Bilgic Water soluble formulation comprising a combination of amlodipine and a statin
TR201009399A2 (en) * 2010-11-11 2012-05-21 Bi̇lgi̇ç Mahmut Rapidly soluble effervescent rosuvastatin formulations.
JP6243265B2 (en) * 2014-03-20 2017-12-06 日医工株式会社 Pharmaceutical preparation containing rosuvastatin
US10413543B2 (en) * 2015-09-01 2019-09-17 Sun Pharma Advanced Research Company Ltd. Stable multiparticulate pharmaceutical composition of rosuvastatin
EP3243506A1 (en) 2016-05-09 2017-11-15 Adamed sp. z o.o. Pharmaceutical composition
KR101954568B1 (en) * 2018-01-22 2019-03-05 한미약품 주식회사 Oral complex formulation comprising omega-3 fatty acid or ester thereof and HMG-CoA reductase inhibitor

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000035425A1 (en) * 1998-12-16 2000-06-22 Lek Pharmaceutical And Chemical Company D.D. STABLE PHARMACEUTICAL FORMULATION COMPRISING A HMG-CoA REDUCTASE INHIBITOR
WO2004010980A1 (en) * 2002-07-25 2004-02-05 Novartis Ag Compositions comprising hmg-coa reductase inhibitor
WO2006006021A2 (en) * 2004-06-28 2006-01-19 Glenmark Pharmaceuticals Limited Stabilized pharmaceutical compositions of preferably a statin
US20070202159A1 (en) * 2006-02-02 2007-08-30 Mathur Rajeev S Pharmaceutical composition comprising stabilized statin particles

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000035425A1 (en) * 1998-12-16 2000-06-22 Lek Pharmaceutical And Chemical Company D.D. STABLE PHARMACEUTICAL FORMULATION COMPRISING A HMG-CoA REDUCTASE INHIBITOR
WO2004010980A1 (en) * 2002-07-25 2004-02-05 Novartis Ag Compositions comprising hmg-coa reductase inhibitor
WO2006006021A2 (en) * 2004-06-28 2006-01-19 Glenmark Pharmaceuticals Limited Stabilized pharmaceutical compositions of preferably a statin
US20070202159A1 (en) * 2006-02-02 2007-08-30 Mathur Rajeev S Pharmaceutical composition comprising stabilized statin particles

Also Published As

Publication number Publication date
WO2008062476A2 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
WO2008062476A3 (en) Pharmaceutical composition comprising rosuvastatin or pharmaceutically accepatble salts thereof
WO2007031933A3 (en) Stable pharmaceutical composition comprising a pyrimidine-sulfamide
WO2008033798A3 (en) A pyrrolopyrazin as syk-kinase inhibitor
WO2009024889A3 (en) Pharmaceutical composition comprising a hmg-coa reductase inhibitor and ezetimibe
AU2007299727A8 (en) Self preserved aqueous pharmaceutical compositions
WO2006082523A3 (en) Pharmaceutical sustained release composition of metformin
WO2008022286A3 (en) Small molecule inhibitors of kynurenine-3-monooxygenase
FI2068839T4 (en) Pharmaceutical compositions comprising nilotinib or its salt
IL197941A0 (en) Use of anilinopyrimidine derivatives for the preparation of pharmaceutical compositions for treating non-alcoholic liver diseases
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
UA93709C2 (en) 12-imidazolyl-1-dodecanol and use thereof in the preparation of pharmaceutical compositions
MY151295A (en) Pyrimidyl indoline compound
IL193252A0 (en) N-hydroxyacrylamide compounds
WO2008001201A3 (en) Pharmaceutical compositions of clopidogrel
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
WO2009145591A3 (en) Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof
WO2008081268A3 (en) Pharmaceutical compositions of entacapone
GR20050100466A (en) IMPROVED PHARMACEUTICAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR AND METHOD FOR THE PREPERATION THEREOF
WO2008020314A3 (en) Statin stabilizing dosage formulations
WO2010023473A3 (en) Crystalline form of sunitinib and processes for its preparation
EP1871396A4 (en) Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor
WO2007110765A3 (en) Processes for the preparation of octreotide
JO2820B1 (en) Combination of a Bisthiazolium Salt or a Precursor Thereof and Artemisinin or a Derivative Thereof for the Treatment of Severe Malaria
WO2009054682A3 (en) Prodrug of atrovastatin by cholesterol's synthesis inhibitors

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07866738

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07866738

Country of ref document: EP

Kind code of ref document: A2